Scrotal Erythema: First Sign of a Cutaneous Drug Reaction to Pazopanib
نویسندگان
چکیده
منابع مشابه
Erythema multiforme as first sign of incomplete Kawasaki disease
Incomplete Kawasaki disease represents a diagnostic challenge for pediatricians. In the absence of classical presentation, the laboratoristic evaluation of systemic inflammation can help in placing the correct diagnosis to promptly start adequate therapy. Erythema multiforme is an acute, self-limiting condition considered to be a hypersensitivity reaction commonly associated with various infect...
متن کاملCutaneous reaction due to ctenocephalides felis felis: a case report
Introduction: Fleas are small, blood-sucking insects that can transmit some pathogens to human and animals. Case Report: This paper presents a 21-year-old woman with severe skin reactions in her right forearm. After initial examinations, the symptoms were recognized as skin reaction caused by the bite of some human blood-sucking insects. Finally, after 15 days of flea bites, the symptoms wer...
متن کاملBullous Annular Erythema as a Cutaneous Sign of Vaginal Stump Adenocarcinoma
Received March 9, 2012, Revised July 4, 2012, Accepted for publication July 15, 2012 Corresponding author: Dae Won Koo, Department of Dermatology, Eulji University Hospital, 95 Dunsanseo-ro, Seo-gu, Daejeon 302-799, Korea. Tel: 82-42-611-3037, Fax: 82-42-259-1111, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commerc...
متن کاملErythema nodosum: a sign of systemic disease.
Erythema nodosum, a painful disorder of the subcutaneous fat, is the most common type of panniculitis. Generally, it is idiopathic, although the most common identifiable cause is streptococcal pharyngitis. Erythema nodosum may be the first sign of a systemic disease such as tuberculosis, bacterial or deep fungal infection, sarcoidosis, inflammatory bowel disease, or cancer. Certain drugs, inclu...
متن کاملA Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
Phosphatidylinositol 3-kinase δ (PIK3δ) is a tyrosine kinase essential for B cell survival, making it an important target in the treatment of chronic lymphocytic leukemia. Idelalisib is an inhibitor of PIK3δ demonstrating initial success in disease response, but is now shown to have a decreased overall survival and life-threatening serious adverse events. The following is an unfortunate case of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Actas Dermo-Sifiliográficas (English Edition)
سال: 2021
ISSN: 1578-2190
DOI: 10.1016/j.adengl.2021.01.012